The induction of tolerance in guinea pigs with a 2,4-dinitrophenyl (DNP) derivative of a copolymer of copolymer of D-glutamic acid and D-lysine (D-GL) leads to a preferential depression of the capacity to produce high affinity anti-DNP antibody in response to immunization with DNP-guinea pig albumin. Thus, immunization 2 wk after tolerance induction with 3 mg of DNP-D-GL results in an immune response in which individual plaque-forming cells (PFC) secreting high affinity anti-DNP antibody are absent and in which the affinity of circulating anti-DNP antibody is reduced. A similar, but less marked, suppression is seen when 0.3 mg of DNP-D-GL is used for tolerance induction. If immunization is delayed until 2 months after tolerance induction, then suppression is restricted to the highest avidity PFC group. Our data is consistent with a state of tolerance in the pool of precursors of anti-DNP antibody-secreting cells induced as a result of their interaction with DNP-D-GL in the absence of specific "helper" cells, which appear to be lacking for DNP-D-GL. In such a situation, the affinity of receptors on precursor cells for tolerogen and the concentration of tolerogen appear to be crucial determinants of whether an individual cell will become tolerant.
Article|
September 01 1972
HAPTEN-SPECIFIC TOLERANCE : PREFERENTIAL DEPRESSION OF THE HIGH AFFINITY ANTIBODY RESPONSE
Joseph M. Davie,
Joseph M. Davie
From the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, and the Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014, and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
William E. Paul,
William E. Paul
From the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, and the Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014, and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
David H. Katz,
David H. Katz
From the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, and the Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014, and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Baruj Benacerraf
Baruj Benacerraf
From the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, and the Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014, and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Joseph M. Davie
From the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, and the Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014, and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
William E. Paul
From the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, and the Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014, and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
David H. Katz
From the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, and the Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014, and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Baruj Benacerraf
From the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, and the Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014, and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Received:
April 25 1972
Online ISSN: 1540-9538
Print ISSN: 0022-1007
Copyright © 1972 by The Rockefeller University Press
1972
J Exp Med (1972) 136 (3): 426–438.
Article history
Received:
April 25 1972
Citation
Joseph M. Davie, William E. Paul, David H. Katz, Baruj Benacerraf; HAPTEN-SPECIFIC TOLERANCE : PREFERENTIAL DEPRESSION OF THE HIGH AFFINITY ANTIBODY RESPONSE . J Exp Med 1 September 1972; 136 (3): 426–438. doi: https://doi.org/10.1084/jem.136.3.426
Download citation file: